Collegium Pharmaceutical, Inc. (COLL)
NASDAQ
Market Cap
$1.04B
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
545 of 809
Rank in Industry
25 of 53
Largest Insider Buys in Sector
COLL Stock Price History Chart
COLL Stock Performance
About Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Insider Activity of Collegium Pharmaceutical, Inc.
Over the last 12 months, insiders at Collegium Pharmaceutical, Inc. have bought $0 and sold $10.51M worth of Collegium Pharmaceutical, Inc. stock.
On average, over the past 5 years, insiders at Collegium Pharmaceutical, Inc. have bought $0 and sold $11.05M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $183,600 was made by Brannelly Paul (Executive Vice President & CFO) on 2017‑05‑12.
List of Insider Buy and Sell Transactions, Collegium Pharmaceutical, Inc.
| 2024-06-03 | Sale | Kuhlmann Shirley R. | EVP and General Counsel | 25,000 0.0771% | $32.57 | $814,180 | -1.73% | |
| 2024-05-28 | Sale | Tupper Colleen | EVP & Chief Financial Officer | 19,710 0.06% | $34.21 | $674,368 | -7.24% | |
| 2024-05-24 | Sale | Dreyer Scott | EVP & Chief Commercial Officer | 56,807 0.1745% | $33.98 | $1.93M | -6.82% | |
| 2024-05-23 | Sale | Dreyer Scott | EVP & Chief Commercial Officer | 51,209 0.1565% | $33.82 | $1.73M | -5.61% | |
| 2024-05-14 | Sale | BOHLIN GAREN G | director | 28,985 0.086% | $32.30 | $936,311 | -2.57% | |
| 2024-02-29 | Sale | Smith Thomas B | EVP and Chief Medical Officer | 995 0.0031% | $36.76 | $36,580 | -2.19% | |
| 2024-02-26 | Sale | Dreyer Scott | EVP & Chief Commercial Officer | 10,000 0.0312% | $36.43 | $364,270 | -0.68% | |
| 2024-01-16 | Sale | Dreyer Scott | EVP & Chief Commercial Officer | 23,560 0.0725% | $32.28 | $760,519 | +6.74% | |
| 2023-12-21 | Sale | Ciaffoni Joseph | President and CEO | 4,357 0.0134% | $30.38 | $132,377 | +11.21% | |
| 2023-12-20 | Sale | Ciaffoni Joseph | President and CEO | 26,454 0.0825% | $30.40 | $804,210 | +12.96% | |
| 2023-12-19 | Sale | Ciaffoni Joseph | President and CEO | 14,516 0.0446% | $30.03 | $435,942 | +12.55% | |
| 2023-12-18 | Sale | Ciaffoni Joseph | President and CEO | 27,798 0.0854% | $30.04 | $834,935 | +12.30% | |
| 2023-11-27 | Sale | Kuhlmann Shirley R. | EVP and General Counsel | 25,600 0.0781% | $25.78 | $660,014 | +28.91% | |
| 2023-06-26 | Sale | Kuhlmann Shirley R. | EVP and General Counsel | 17,984 0.0534% | $21.72 | $390,633 | +42.43% | |
| 2023-06-02 | Sale | Ciaffoni Joseph | President and CEO | 31,272 0.091% | $21.60 | $675,424 | +20.39% | |
| 2023-06-01 | Sale | Ciaffoni Joseph | President and CEO | 31,272 0.0901% | $22.09 | $690,758 | +16.47% | |
| 2023-05-31 | Sale | Ciaffoni Joseph | President and CEO | 31,272 0.0903% | $21.87 | $683,797 | +17.90% | |
| 2023-05-30 | Sale | Ciaffoni Joseph | President and CEO | 31,271 0.0915% | $21.90 | $684,907 | +18.62% | |
| 2023-03-15 | Sale | Tupper Colleen | EVP & Chief Financial Officer | 31,640 0.0947% | $23.77 | $752,165 | -0.59% | |
| 2023-03-01 | Sale | Dreyer Scott | EVP & Chief Commercial Officer | 13,324 0.0395% | $26.70 | $355,751 | -12.24% |
Insider Historical Profitability
42.23%
| Ciaffoni Joseph | President and CEO | 275000 0.8433% | $31.83 | 0 | 31 | |
| Kuhlmann Shirley R. | EVP and General Counsel | 139409 0.3665% | $31.83 | 0 | 9 | |
| Dreyer Scott | EVP & Chief Commercial Officer | 105902 0.3414% | $31.83 | 0 | 15 | |
| Tupper Colleen | EVP & Chief Financial Officer | 130845 0.3233% | $31.83 | 0 | 3 | |
| Smith Thomas B | EVP and Chief Medical Officer | 63409 0.1984% | $31.83 | 0 | 1 | |
| BOHLIN GAREN G | director | 44775 0.1369% | $31.83 | 0 | 1 | |
| Freund John Gordon | 2949916 9.0458% | $31.83 | 1 | 0 | +44.38% | |
| Skyline Venture Partners V LP | 10 percent owner | 2949916 9.0458% | $31.83 | 1 | 0 | +44.38% |
| Heron Patrick J | 1887332 5.7874% | $31.83 | 1 | 0 | +44.38% | |
| Frazier Healthcare VI, L.P. | 10 percent owner | 1887332 5.7874% | $31.83 | 1 | 0 | +44.38% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1325253 4.0638% | $31.83 | 1 | 0 | +44.38% | |
| Fleming Alison B | Chief Technical Officer | 148753 0.4561% | $31.83 | 0 | 12 | |
| Brannelly Paul | Executive Vice President & CFO | 123436 0.3785% | $31.83 | 1 | 1 | +42.57% |
| Longitude Capital Partners, LLC | 10 percent owner | 45620 0.1399% | $31.83 | 1 | 1 | +44.38% |
| Heffernan Michael Thomas | director | 28023 0.0859% | $31.83 | 0 | 25 | |
| Hirsch David | director | 17117 0.0525% | $31.83 | 1 | 3 | +44.38% |
| Fallon John A. | director | 2375 0.0073% | $31.83 | 1 | 0 | +26.87% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| BlackRock | $227.71M | 17.93 | 5.87M | +1.36% | +$3.06M | 0.01 | |
| Eventide Asset Management | $102.25M | 8.05 | 2.63M | +0.14% | +$138,315.66 | 1.61 | |
| Pacer Advisors Inc | $100.42M | 7.91 | 2.59M | +18.95% | +$16M | 0.25 | |
| The Vanguard Group | $90.48M | 7.12 | 2.33M | +0.78% | +$696,508.44 | <0.01 | |
| Helm Capital Management LLC | $71.2M | 5.61 | 1.83M | -33.51% | -$35.88M | 2.11 | |
| Invesco | $63.34M | 4.99 | 1.63M | +13.18% | +$7.38M | 0.01 | |
| Renaissance Technologies | $55.05M | 4.34 | 1.42M | +2.43% | +$1.3M | 0.09 | |
| State Street | $51.21M | 4.03 | 1.32M | +0.39% | +$201,087.60 | <0.01 | |
| Dimensional Fund Advisors | $39.56M | 3.12 | 1.02M | -1.93% | -$779,117.39 | 0.01 | |
| Fuller & Thaler Asset Management, Inc. | $37.62M | 2.96 | 969,199 | New | +$37.62M | 0.17 | |
| Camber Capital Management Lp | $33.11M | 2.61 | 852,900 | -18.77% | -$7.65M | 1.17 | |
| Morgan Stanley | $32.49M | 2.56 | 836,944 | -16.45% | -$6.4M | <0.01 | |
| Geode Capital Management | $28.48M | 2.24 | 733,548 | +0.31% | +$88,600.77 | <0.01 | |
| Emerald Advisers, Inc. | $25.99M | 2.05 | 669,512 | +0.51% | +$132,609.12 | 1.06 | |
| Massachusetts Financial Services Co Ma | $25.69M | 2.02 | 661,798 | -0.5% | -$128,882.40 | 0.01 | |
| Janus Henderson | $21.87M | 1.72 | 563,405 | -10.22% | -$2.49M | 0.01 | |
| ROCK SPRINGS CAPITAL MANAGEMENT, LP | $21.82M | 1.72 | 562,000 | 0% | +$0 | 0.56 | |
| Victory Capital Management Inc | $20.42M | 1.61 | 525,963 | -27.28% | -$7.66M | 0.02 | |
| EMERALD MUTUAL FUND ADVISERS TRUST | $19.84M | 1.56 | 511,201 | -7.36% | -$1.58M | 1.05 | |
| Northern Trust | $14.91M | 1.17 | 384,039 | -4.2% | -$653,262.96 | <0.01 | |
| LSV Asset Management | $14.77M | 1.16 | 380,551 | +188.73% | +$9.66M | 0.03 | |
| Avidity Partners Management Lp | $14.03M | 1.11 | 361,400 | +<0.01% | +$1,436.34 | 0.51 | |
| Charles Schwab | $13.22M | 1.04 | 340,433 | +11.45% | +$1.36M | <0.01 | |
| Federated Hermes | $12.79M | 1.01 | 329,531 | +54.88% | +$4.53M | 0.03 | |
| BNY Mellon | $11.94M | 0.94 | 307,631 | -4.66% | -$583,114.27 | <0.01 | |
| ROYCE & ASSOCIATES INC | $11.21M | 0.88 | 288,709 | +101.78% | +$5.65M | 0.1 | |
| Arrowstreet Capital, Limited Partnership | $10.81M | 0.85 | 278,513 | +26.97% | +$2.3M | 0.01 | |
| Loomis, Sayles & Company | $10.56M | 0.83 | 271,952 | -1.51% | -$162,148.43 | 0.02 | |
| Two Sigma Advisers LP | $10.39M | 0.82 | 267,700 | +9.27% | +$881,214.00 | 0.02 | |
| Man Group Plc | $10.13M | 0.8 | 260,936 | +366.13% | +$7.96M | 0.03 | |
| Elequin Securities Llc | $9.53M | 0.75 | 244,516 | New | +$9.53M | 0.37 | |
| Penn Capital Management Co Inc | $9.53M | 0.75 | 244,516 | -22.57% | -$2.78M | 0.37 | |
| Two Sigma | $8.77M | 0.69 | 225,806 | -13.09% | -$1.32M | 0.02 | |
| Brandywine Global Investment Management | $8.01M | 0.63 | 206,414 | -44.83% | -$6.51M | 0.06 | |
| D. E. Shaw & Co. | $7.73M | 0.61 | 199,149 | -10.09% | -$867,859.90 | 0.01 | |
| Bank of America | $7.71M | 0.61 | 198,498 | +970.3% | +$6.99M | <0.01 | |
| Millennium Management LLC | $7.51M | 0.59 | 193,371 | -56.41% | -$9.72M | 0.01 | |
| Quantedge | $6.69M | 0.53 | 172,300 | New | +$6.69M | 2.88 | |
| Goldman Sachs | $6.36M | 0.5 | 163,950 | -20.05% | -$1.6M | <0.01 | |
| South Dakota Investment Council | $6.13M | 0.48 | 157,772 | -35.27% | -$3.34M | 0.13 | |
| New York State Common Retirement Fund | $6.07M | 0.48 | 156,316 | -22.27% | -$1.74M | 0.01 | |
| Uniplan Investment Counsel Inc | $5.7M | 0.45 | 146,918 | -0.12% | -$6,793.07 | 0.47 | |
| AllianceBernstein | $5.08M | 0.4 | 130,750 | -18.17% | -$1.13M | <0.01 | |
| JPMorgan Chase | $4.87M | 0.38 | 125,356 | -44.47% | -$3.9M | <0.0001 | |
| Citadel Advisors LLC | $4.38M | 0.35 | 112,743 | +2.02% | +$86,762.70 | <0.01 | |
| Hillsdale Investment Management Inc. | $4.33M | 0.34 | 111,500 | +18.24% | +$667,704.00 | 0.36 | |
| LINSCO PRIVATE LEDGER CORP | $4.26M | 0.34 | 109,786 | -8.42% | -$391,771.48 | <0.01 | |
| AQR Capital | $4.24M | 0.33 | 109,126 | +3.77% | +$153,727.19 | 0.01 | |
| Trexquant Investment LP | $4.2M | 0.33 | 108,227 | +14.43% | +$529,892.98 | 0.06 | |
| Third Avenue Management | $4.2M | 0.33 | 108,120 | +30.08% | +$970,499.91 | 0.67 |